Related references
Note: Only part of the references are listed.Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease
Hengameh Chloe Mirsepasi-Lauridsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease
Y. Zhulina et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy
Rocio Ferreiro-Iglesias et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Prediction of Endoscopic Disease Activity in Ulcerative Colitis by Two Different Assays for Fecal Calprotectin
Vendel Kristensen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
A. Dhaliwal et al.
FRONTLINE GASTROENTEROLOGY (2015)
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics
Matthijs Oyaert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings
Charlotte R. Hedin et al.
GUT (2014)
Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Orebro, Sweden: A population-based retrospective study
Yaroslava Zhulina et al.
JOURNAL OF CROHNS & COLITIS (2014)
Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease
Delphine Labaere et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)
Subclinical Inflammation with Increased Neutrophil Activity in Healthy Twin Siblings Reflect Environmental Influence in the Pathogenesis of Inflammatory Bowel Disease
Yaroslava Zhulina et al.
INFLAMMATORY BOWEL DISEASES (2013)
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
Martine De Vos et al.
INFLAMMATORY BOWEL DISEASES (2013)
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
S. J. Whitehead et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
James D. Lewis
GASTROENTEROLOGY (2011)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Dorota Walkiewicz et al.
INFLAMMATORY BOWEL DISEASES (2008)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease
SK Bunn et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2001)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Improved assay for fecal calprotectin
H Ton et al.
CLINICA CHIMICA ACTA (2000)
Share Paper
